Patents by Inventor Malcolm J. Begemann

Malcolm J. Begemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7519423
    Abstract: A method of pacing opposing chambers of a heart with a pacing system is provided. The pacing system comprises a first bipolar medical electrical lead having at least one first electrode configured for positioning in a first opposing chamber of the heart, a second bipolar medical electrical lead having at least one second electrode configured for positioning in a second opposing chamber of the heart, an implantable pulse generator operably connected to the first and second bipolar medical electrical leads. The implantable pulse generator further comprises a hermetically sealed housing capable of serving as a can electrode. The method designates a primary electrode configuration by selecting a cathode and an anode from either the first electrode, second electrode, or the can. Selection of the cathode is based on a comparison of thresholds measured in each chamber. Systems, programs and devices using the method are also provided.
    Type: Grant
    Filed: August 29, 2005
    Date of Patent: April 14, 2009
    Assignee: Medtronic, Inc.
    Inventors: Malcolm J. Begemann, Geeske Van Oort
  • Patent number: 6950701
    Abstract: A method of pacing opposing chambers of a heart with a pacing system is provided. The pacing system comprises a first unipolar medical electrical lead having at least one first electrode configured for positioning in a first opposing chamber of the heart, a second unipolar medical electrical lead having at least one second electrode configured for positioning in a second opposing chamber of the heart, an implantable pulse generator operably connected to the first and second unipolar medical electrical leads. The implantable pulse generator further comprises an hermetically sealed housing capable of serving as a can electrode, and means for switching electrode configurations between the first electrode and the can electrode, between the second electrode and the can electrode, between the first electrode and the second electrode and between the second electrode and the first electrode. A primary electrode configuration is determined.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: September 27, 2005
    Assignee: Medtronic, Inc.
    Inventors: Malcolm J. Begemann, Geeske Van Oort
  • Publication number: 20040215261
    Abstract: A soothing program for anti-atrial tachyarrhymia therapy operates within a natural intrinsic atrial rate band for increased patient comport and improved therapy. The implantable pacemakers is configured with an atrial event detector, an anti-atrial tachyarrhymia progam that produces an anti-tachyarrhymia therapy, and a soothing program. The soothing program resides in memory and adjusts the anti-atrial tachyarrhymia program. The soothing program has an acceleration rate within a natural intrinsic atrial rate band upon detection of an atrial tachyarrhymia event and a deceleration rate also within the natural intrinsic atrial rate band to adjust the anti-atrial tachyarrhymia therapy. Some embodiments can adjust the anti-atrial tachyarrhymia therapy to maintain natural atrial activation and reduce patient discomfort such as palpitations.
    Type: Application
    Filed: April 25, 2003
    Publication date: October 28, 2004
    Inventors: Malcolm J. Begemann, Johannes S. Van Der Veen, Henk Westendorp, Xander Evers, Willem Stegink
  • Publication number: 20040138715
    Abstract: A system and method for an implantable cardiac pacing device provide for delivery of anti-tachycardia pacing of the atrium upon detection of atrial tachycardia combined with automatic re-synchronization of ventricular pacing directly following the last atrial pulse of the anti-tachycardia scheme. At the onset of delivery of the ATP train or like scheme of ATP, an appropriate ventricular pacing interval is calculated to enable asynchronous pacing of the ventricle during the ATP and synchronous delivery of the next ventricular pulse at a delay following the end of the ATP train. Upon determination of AT, an algorithm is used to calculate if a ventricular pacing interval can be found that meets maximum and minimum pacing criteria and also provides that the next ventricular pace pulse following the end of the ATP train will follow the last atrial pulse of the train by a suitable AV delay.
    Type: Application
    Filed: May 12, 2003
    Publication date: July 15, 2004
    Inventors: Christianus J.J.E. van Groeningen, Joanneke Gerrigje Groen, Malcolm J. Begemann
  • Patent number: 6636762
    Abstract: A method of monitoring heart failure is provided. A baseline heart rate change value is determined, wherein the baseline heart rate change value comprises a speed at which a first initial heart rate changes to a second initial heart rate. At least one subsequent heart rate change value is also determined, wherein the subsequent heart rate change value comprises a subsequent speed at which a first subsequent heart rate changes to a second subsequent heart rate. The subsequent heart rate change value is compared to the baseline heart rate change value to obtain at least one heart failure value. Systems and programs for using the method are also provided.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: October 21, 2003
    Assignee: Medtronic, Inc.
    Inventor: Malcolm J. Begemann
  • Patent number: 6629931
    Abstract: A method of measuring a source impedance of at least one cardiac electrical signal in a mammalian heart is provided. A first amplifier system is operated. A first signal from a chamber of the heart is received. The first signal is passed through a first amplifier. A second amplifier system is then operated. A second signal from the chamber of the heart is received. The second signal is passed through a second amplifier. Finally, the source impedance of at least one cardiac electrical signal is calculated. The source impedance is based on the amplified first signal and the amplified second signal.
    Type: Grant
    Filed: November 6, 2000
    Date of Patent: October 7, 2003
    Assignee: Medtronic, Inc.
    Inventors: Malcolm J. Begemann, Willem Boute
  • Publication number: 20030120313
    Abstract: A method of pacing opposing chambers of a heart with a pacing system is provided. The pacing system comprises a first unipolar medical electrical lead having at least one first electrode configured for positioning in a first opposing chamber of the heart, a second unipolar medical electrical lead having at least one second electrode configured for positioning in a second opposing chamber of the heart, an implantable pulse generator operably connected to the first and second unipolar medical electrical leads. The implantable pulse generator further comprises an hermetically sealed housing capable of serving as a can electrode, and means for switching electrode configurations between the first electrode and the can electrode, between the second electrode and the can electrode, between the first electrode and the second electrode and between the second electrode and the first electrode. A primary electrode configuration is determined.
    Type: Application
    Filed: December 21, 2001
    Publication date: June 26, 2003
    Inventors: Malcolm J. Begemann, Geeske Van Oort
  • Patent number: 6526311
    Abstract: An improved system and method for analyzing far-filed R-waves detected by a sensing device located in the atrium of a patient's heart are provided.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: February 25, 2003
    Assignee: Medtronic, Inc.
    Inventor: Malcolm J. Begemann
  • Publication number: 20020198462
    Abstract: A method of monitoring heart failure is provided. A baseline heart rate change value is determined, wherein the baseline heart rate change value comprises a speed at which a first initial heart rate changes to a second initial heart rate. At least one subsequent heart rate change value is also determined, wherein the subsequent heart rate change value comprises a subsequent speed at which a first subsequent heart rate changes to a second subsequent heart rate. The subsequent heart rate change value is compared to the baseline heart rate change value to obtain at least one heart failure value. Systems and programs for using the method are also provided.
    Type: Application
    Filed: April 30, 2001
    Publication date: December 26, 2002
    Inventor: Malcolm J. Begemann
  • Publication number: 20020040191
    Abstract: An improved system and method for analyzing far-filed R-waves detected by a sensing device located in the atrium of a patient's heart are provided.
    Type: Application
    Filed: July 30, 2001
    Publication date: April 4, 2002
    Inventor: Malcolm J. Begemann